Also see: MDL Monsanto Glyphosate Cancer Case Key Documents and Analysisand US Right to Know Sues EPA for Release of Glyphosate Documents By Carey Gillam The puzzle pieces are starting to fall into place, but so far it’s not a pretty picture. A series of internal Monsanto Co. documents revealed this week via a court … Monsanto Weed Killer: Scientific Manipulation Revealed
What “ghostwriting” by Monsanto means, how it has influenced, and still is influencing, material found in peer-reviewed scientific journals Thisarticlewasoriginallypublishedin EnvironmentalHealthNews. By Carey Gillam and Nathan Donley Consumers and journalists around the world were stunned earlier this month when Monsanto, after being forced in a court of law for the first time to defend the … A Story Behind the Monsanto Cancer Trial — Journal Sits on Retraction
By Carey Gillam Three years ago this month Monsanto executives realized they had a big problem on their hands. It was September 2014 and the company’s top-selling chemical, the weed killer called glyphosate that is the foundation for Monsanto’s branded Roundup products, had been selected as one among a handful of pesticides to undergo scrutiny … How Monsanto Manufactured ‘Outrage’ at IARC over Cancer Classification
Update: The ATSDR published their draft toxicological profile for glyphosate in April 2019. See coverage: ATSDR Report Confirms Glyphosate Cancer Risks, NRDC (4.11.2019); Some Links to Cancer Shown in Draft Review of Common Pesticide, Bloomberg (4.8.2019); Emails Show Monsanto Cozy with Feds, Courthouse News (4.15.2019). This article by Carey Gillam was originally published in Huffington … Read the emails, texts that show EPA efforts to slow ATSDR glyphosate review
